These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging. Ohno Y; Yui M; Aoyagi K; Kishida Y; Seki S; Koyama H; Yoshikawa T AJR Am J Roentgenol; 2019 Feb; 212(2):311-319. PubMed ID: 30512992 [TBL] [Abstract][Full Text] [Related]
4. Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma. Kitajima K; Doi H; Kuribayashi K Jpn J Radiol; 2016 Aug; 34(8):537-47. PubMed ID: 27222020 [TBL] [Abstract][Full Text] [Related]
6. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma? Sharif S; Zahid I; Routledge T; Scarci M Interact Cardiovasc Thorac Surg; 2011 May; 12(5):806-11. PubMed ID: 21266493 [TBL] [Abstract][Full Text] [Related]
7. Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It? Pinelli V; Roca E; Lucchini S; Laroumagne S; Loundou A; Dutau H; Maldonado F; Astoul P Respiration; 2015; 89(6):558-64. PubMed ID: 25966972 [TBL] [Abstract][Full Text] [Related]
8. Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. Gerbaudo VH; Sugarbaker DJ; Britz-Cunningham S; Di Carli MF; Mauceri C; Treves ST J Nucl Med; 2002 Sep; 43(9):1144-9. PubMed ID: 12215551 [TBL] [Abstract][Full Text] [Related]
9. Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma. Kitajima K; Kuribayashi K; Minami T; Yokoyama H; Nakamura A; Hashimoto M; Kijima T; Hasegawa S; Kaida H; Yamakado K Oncotarget; 2024 Jun; 15():408-417. PubMed ID: 38900646 [TBL] [Abstract][Full Text] [Related]
10. FDG PET/CT for Staging and Restaging Malignant Mesothelioma. Lopci E; Castello A; Mansi L Semin Nucl Med; 2022 Nov; 52(6):806-815. PubMed ID: 35965111 [TBL] [Abstract][Full Text] [Related]
11. Elliott HS; Metser U; de Perrot M; Cho J; Bradbury P; Veit-Haibach P; Hussey D; Noam T Br J Radiol; 2018 Jun; 91(1086):20170814. PubMed ID: 29498536 [TBL] [Abstract][Full Text] [Related]
12. Histology of the pleural rind at [ Soltermann A; Opitz I; Burger IA Pathol Res Pract; 2021 Dec; 228():153660. PubMed ID: 34749212 [TBL] [Abstract][Full Text] [Related]
13. Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma. Wilcox BE; Subramaniam RM; Peller PJ; Aughenbaugh GL; Nichols Iii FC; Aubry MC; Jett JR Clin Lung Cancer; 2009 Jul; 10(4):244-8. PubMed ID: 19632941 [TBL] [Abstract][Full Text] [Related]
14. Spectrum of malignant pleural and pericardial disease on FDG PET/CT. Makis W; Ciarallo A; Hickeson M; Rush C; Novales-Diaz JA; Derbekyan V; Laufer J; Stern J; Lisbona R AJR Am J Roentgenol; 2012 Mar; 198(3):678-85. PubMed ID: 22358009 [TBL] [Abstract][Full Text] [Related]
15. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma. Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889 [TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma. Schneider DB; Clary-Macy C; Challa S; Sasse KC; Merrick SH; Hawkins R; Caputo G; Jablons D J Thorac Cardiovasc Surg; 2000 Jul; 120(1):128-33. PubMed ID: 10884665 [TBL] [Abstract][Full Text] [Related]
17. What is the best way to diagnose and stage malignant pleural mesothelioma? Zahid I; Sharif S; Routledge T; Scarci M Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):254-9. PubMed ID: 21044972 [TBL] [Abstract][Full Text] [Related]
19. Current trends in radiologic management of malignant pleural mesothelioma. Gill RR; Gerbaudo VH; Sugarbaker DJ; Hatabu H Semin Thorac Cardiovasc Surg; 2009; 21(2):111-20. PubMed ID: 19822282 [TBL] [Abstract][Full Text] [Related]
20. FDG PET/CT is useful for detecting infiltration to the port site in patients with malignant pleural mesothelioma. Kawaguchi K; Taniguchi T; Usami N; Fukui T; Ishiguro F; Nakamura S; Yokoi K Gen Thorac Cardiovasc Surg; 2014 Mar; 62(3):157-62. PubMed ID: 24281913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]